Listerine meeting rescheduled
This article was originally published in The Rose Sheet
Executive Summary
"Feedback" meeting on Listerine-manufacturer Pfizer's efforts to amend the OTC anticaries final monograph, originally slated for June 18, will be held Aug. 27 at 9201 Corporate Blvd., Rockville, Md., FDA says. At the meeting, Pfizer will seek agency review and confirmation that treatment cells and statistical criteria in its proposed six-month gingivitis study on the .02% sodium fluoride mouthrinse are acceptable and may allow for product's inclusion in the monograph...
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.